Cargando…

Giant Cell Arteritis versus Takayasu Arteritis: An Update

Giant cell arteritis (GCA) and Takayasu Arteritis (TAK) are two systemic granulomatous vasculitides affecting medium- and large-sized arteries. Similarities in GCA and TAK regarding the clinical presentation, the systemic inflammatory response and the distribution of the arterial lesions, have trigg...

Descripción completa

Detalles Bibliográficos
Autor principal: Stamatis, Pavlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362112/
https://www.ncbi.nlm.nih.gov/pubmed/32676554
http://dx.doi.org/10.31138/mjr.31.2.174
_version_ 1783559443963707392
author Stamatis, Pavlos
author_facet Stamatis, Pavlos
author_sort Stamatis, Pavlos
collection PubMed
description Giant cell arteritis (GCA) and Takayasu Arteritis (TAK) are two systemic granulomatous vasculitides affecting medium- and large-sized arteries. Similarities in GCA and TAK regarding the clinical presentation, the systemic inflammatory response and the distribution of the arterial lesions, have triggered a debate over the last decade about whether GCA and TAK represent two different diseases, or are age-associated different clinical phenotypes of the same disease. On the other hand, there are differences regarding epidemiology, several clinical features (eg, polymyalgia rheumatica in GCA) and treatment. The aim of this review is to present the latest data regarding this question and to shed some light on the differences and similarities between GCA and TAK regarding epidemiology, genetics, pathogenesis, histopathology, clinical presentation, imaging and treatment. The existing data in literature support the opinion that GCA and TAK are different clinical entities.
format Online
Article
Text
id pubmed-7362112
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Mediterranean Journal of Rheumatology (MJR)
record_format MEDLINE/PubMed
spelling pubmed-73621122020-07-15 Giant Cell Arteritis versus Takayasu Arteritis: An Update Stamatis, Pavlos Mediterr J Rheumatol Viewpoint Giant cell arteritis (GCA) and Takayasu Arteritis (TAK) are two systemic granulomatous vasculitides affecting medium- and large-sized arteries. Similarities in GCA and TAK regarding the clinical presentation, the systemic inflammatory response and the distribution of the arterial lesions, have triggered a debate over the last decade about whether GCA and TAK represent two different diseases, or are age-associated different clinical phenotypes of the same disease. On the other hand, there are differences regarding epidemiology, several clinical features (eg, polymyalgia rheumatica in GCA) and treatment. The aim of this review is to present the latest data regarding this question and to shed some light on the differences and similarities between GCA and TAK regarding epidemiology, genetics, pathogenesis, histopathology, clinical presentation, imaging and treatment. The existing data in literature support the opinion that GCA and TAK are different clinical entities. The Mediterranean Journal of Rheumatology (MJR) 2020-06-30 /pmc/articles/PMC7362112/ /pubmed/32676554 http://dx.doi.org/10.31138/mjr.31.2.174 Text en © 2020 The Mediterranean Journal of Rheumatology (MJR) http://creativecommons.org/licenses/by/4.0/ This work is licensed under and Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Viewpoint
Stamatis, Pavlos
Giant Cell Arteritis versus Takayasu Arteritis: An Update
title Giant Cell Arteritis versus Takayasu Arteritis: An Update
title_full Giant Cell Arteritis versus Takayasu Arteritis: An Update
title_fullStr Giant Cell Arteritis versus Takayasu Arteritis: An Update
title_full_unstemmed Giant Cell Arteritis versus Takayasu Arteritis: An Update
title_short Giant Cell Arteritis versus Takayasu Arteritis: An Update
title_sort giant cell arteritis versus takayasu arteritis: an update
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362112/
https://www.ncbi.nlm.nih.gov/pubmed/32676554
http://dx.doi.org/10.31138/mjr.31.2.174
work_keys_str_mv AT stamatispavlos giantcellarteritisversustakayasuarteritisanupdate